Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05206981 · ClinicalTrials.gov registry record
Device Global Registry for the IlluminOss Bone Stabilization System
A clinical trial of Pathological Fracture and Traumatic Fracture, sponsored by IlluminOss Medical.
- Recruiting
- Registry status
- 300
- Enrollment target
- 16
- Study locations
NCT05206981: Recruiting study of Pathological Fracture and Traumatic Fracture, sponsored by IlluminOss Medical.
NCT05206981 is a study of Pathological Fracture and Traumatic Fracture that is actively recruiting participants, run by IlluminOss Medical. The registered enrollment target is 300 participants. The trial reports 16 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05206981, a study of Pathological Fracture and Traumatic Fracture, is actively recruiting participants, sponsored by IlluminOss Medical.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 16
- Study locations
Study Summary
This is a multi-center, observational patient registry. The primary objective of the study is to collect safety and performance data on the IlluminOss Device when used to provide stabilization and alignment for the treatment of traumatic or impending and pathologic fractures.
Conditions Studied
Interventions
- DEVICE IlluminOss Device
Study Locations (16)
Other
- St Vinzenz Hospital - Cologne
- Johannes Wesling Hospital Minden - Minden
- Petrus Hospital - Wuppertal
Florida
- University of Miami Hospital - Miami
- Weston Outpatient Surgical Center - Weston
North Carolina
- Mission Hospital - Asheville
- Wake Forest Baptist Health - Winston-Salem
Pennsylvania
- Temple University Hospital - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Alabama
- Gulf Orthopedics - Mobile
California
- Cedars-Sinai Medical Center - Los Angeles
Colorado
- Presbyterian St Luke's Medical Ctr - Denver
Indiana
- Parkview Health - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2026-12 |
What NCT05206981 shows while recruiting
NCT05206981 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Pathological Fracture appearing as the primary indexed condition, and to 1 intervention - of which IlluminOss Device is the first listed.
NCT05206981 lists 16 locations in 11 states (Other, Florida, North Carolina).
Frequently Asked Questions
What is clinical trial NCT05206981 about?
NCT05206981 is a clinical study titled "Device Global Registry for the IlluminOss Bone Stabilization System". This is a multi-center, observational patient registry. The primary objective of the study is to collect safety and performance data on the IlluminOss Device when used to provide stabilization and alignment for the treatment of traumatic or impending and pathologic fractures.
What is the current status of trial NCT05206981?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2021-06-11. Estimated completion is 2026-12.
What conditions does trial NCT05206981 study?
This clinical trial studies the following conditions: Pathological Fracture, Traumatic Fracture.
What interventions are being tested in trial NCT05206981?
The interventions under investigation include: IlluminOss Device (DEVICE).
Who is sponsoring clinical trial NCT05206981?
This trial is sponsored by IlluminOss Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05206981 being conducted?
This trial has 16 study locations across Alabama, California, Colorado, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pathological Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI